Cathy is a partner at Cervin Ventures and an experienced Blockchain Analyst and Advisor. She was CEO and co-founder at Ranomics, a venture backed genomics company that created a first-of-its-kind knowledge base of gene function information that enabled clinicians to understand the biological consequences of genetic variants. Cathy also led the launch of VariantFindTM, a gene variant synthesis platform that enables antibody optimization, drug target validation, and enzyme, protein and organism engineering.
Cathy founded Ranomics at the age of 18, and was named a Thiel Fellow in 2015 and Forbes 30 under 30 in 2018.